Investors

Elixir Medical is a privately funded company. The lead investor is The Invus Group, a New York-based equity investment firm with over $4 billion under management.

Elixir's strength is its highly driven and experienced team. Our founders and employees have a proven track record of success in bringing innovative therapies to market.